[Autoantibodies in Paraneoplastic Neurological Syndrome]

Izumi Kawachi1

  • 1Department of Neurology, Brain Research Institute, Niigata University.

Insights

Paraneoplastic neurological syndromes (PNS) arise from anti-tumor immune responses targeting the nervous system. Identifying specific onconeuronal antibodies aids early tumor detection and treatment, improving patient outcomes.

Area of Science:

  • Neuroimmunology
  • Oncology
  • Neurology

Background:

  • Paraneoplastic neurological syndromes (PNS) result from immune responses to tumor-expressed neuronal antigens.
  • Onconeuronal antibodies are classified based on immunological mechanisms and treatment responses into intracellular and surface/synaptic antigen targets.
  • Advances in identifying onconeuronal antibodies have significantly reshaped understanding of central nervous system (CNS) autoimmunity and PNS.

Purpose of the Study:

  • To review characteristic onconeuronal antibodies, such as anti-Hu, anti-Ma2, and anti-N-methyl-D-aspartate receptor (NMDAR).
  • To discuss the diagnostic algorithm for paraneoplastic neurological syndromes.
  • To highlight the importance of PNS recognition for early tumor detection and prompt treatment initiation.

Main Methods:

  • Literature review of onconeuronal antibodies and their associated neurological syndromes.
  • Analysis of immunological pathomechanisms and treatment responsiveness.
  • Discussion of diagnostic strategies and algorithms for PNS.

Main Results:

  • Onconeuronal antibodies are key biomarkers in PNS, targeting distinct neuronal antigens.
  • Specific antibodies like anti-Hu, anti-Ma2, and anti-NMDAR are associated with characteristic clinical syndromes.
  • Early detection of PNS through antibody identification facilitates timely diagnosis of underlying malignancies.

Conclusions:

  • Recognition and characterization of onconeuronal antibodies are crucial for diagnosing PNS.
  • Prompt diagnosis and treatment of PNS can lead to substantial clinical improvement.
  • Understanding PNS pathogenesis aids in managing CNS autoimmunity and associated cancers.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
689
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.1K
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
583
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
355
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
249